{"id":11032,"date":"2024-08-14T13:37:00","date_gmt":"2024-08-14T08:07:00","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=11032"},"modified":"2026-03-20T17:47:38","modified_gmt":"2026-03-20T12:17:38","slug":"breast-cancer-symptoms-causes-treatment","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment","title":{"rendered":"Breast Cancer Insights: Identifying Symptoms and Protecting Your Health"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69feb6f4afd92\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69feb6f4afd92\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#What_is_Breast_Cancer\" >What is Breast Cancer?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#Types_and_Subtypes_of_Breast_Cancer\" >Types and Subtypes of Breast Cancer<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#What_are_the_Causes_of_Breast_Cancer\" >What are the Causes of Breast Cancer?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#Some_of_the_Risk_Factors_for_Breast_Cancer_are_as_Follows\" >Some of the Risk Factors for Breast Cancer are as Follows:&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#How_can_you_Reduce_the_Chances_of_Breast_Cancer\" >How can you Reduce the Chances of Breast Cancer?&nbsp;<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#What_are_the_Early_Signs_of_Breast_Cancer\" >What are the Early Signs of Breast Cancer?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#How_do_These_Signs_Differ_in_Case_Breast_Cancer_has_Spread_to_Other_Parts\" >How do These Signs Differ in Case, Breast Cancer has Spread to Other Parts?&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#When_and_How_is_Breast_Cancer_Diagnosed\" >When and How is Breast Cancer Diagnosed?&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#What_are_the_Treatment_Options_Available_for_Breast_Cancer\" >What are the Treatment Options Available for Breast Cancer?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n\n<p>Breast cancer is the most common form of cancer in women. Each year, it affects over 2 million women globally and is the most significant cause of death among women. Among the many types of breast cancer, a particularly formidable foe is <a href=\"https:\/\/www.delveinsight.com\/report-store\/triple-negative-breast-cancer-tnbc-market\">Triple-negative breast cancer (TNBC)<\/a>, which accounts for 10-20% of all cases. Other than this, breast cancer statistics show that HR+\/HER2\u2212 cases were highest in the US, with about 208K cases in 2023, predominantly affecting those aged 60 to 79 years. Germany had the highest number in the EU4 and UK, with 50K cases, while Spain had the fewest. Japan reported around 43K cases. Breast cancer is the most common cancer in U.S. women, excluding skin cancers, representing about 30% of all new female cancers. The HR+\/HER2\u2212 subtype is the most common, with an incidence rate of 87.2% cases per 100K women, predominantly affecting postmenopausal women.&nbsp;<\/p>\n\n\n\n<p>Let\u2019s explore the essential aspects of breast cancer to build a strong foundation for understanding this complex disease.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-is-breast-cancer\"><span class=\"ez-toc-section\" id=\"What_is_Breast_Cancer\"><\/span>What is Breast Cancer?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/breast-cancer-market\">Breast cancer<\/a> is a type of disease in which the cells in the breasts start to grow uncontrollably. These cells can reside in different parts of the breasts, i.e., lobules, ducts, and connective tissue, and thus on the basis of the location of cells, there are different types of breast cancers. Most commonly, breast cancer begins in lobules that are milk-producing glands. It can also begin in ducts that act as the passage of the milk from lobules to the nipples. However, very rarely, there are chances of developing cancer in connective tissues in the breasts.&nbsp;<\/p>\n\n\n\n<p>Breast cancer may begin anywhere in the breasts, but through the blood or lymph system, it can spread to other parts of the body. If the <a href=\"https:\/\/www.delveinsight.com\/blog\/metastatic-her2-positive-breast-cancer-2\/\">cancer cell spreads <\/a>to lymph nodes, there are higher chances of cancer spreading to the lymph system and metastasizing to other organs.&nbsp; However, not all cases of cancer metastasize.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-types-and-subtypes-of-breast-cancer\"><span class=\"ez-toc-section\" id=\"Types_and_Subtypes_of_Breast_Cancer\"><\/span>Types and Subtypes of Breast Cancer<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Breast cancer includes various types and subtypes. The main types are Ductal Carcinoma In Situ (DCIS), Invasive Ductal Carcinoma (IDC), Invasive Lobular Carcinoma (ILC), and Lobular Carcinoma In Situ (LCIS). Subtypes of IDC include tubular, medullary, mucinous, papillary, and cribriform carcinoma. <a href=\"https:\/\/www.delveinsight.com\/blog\/key-facts-to-know-about-triple-negative-breast-cancer-tnbc\">Triple-Negative Breast Cancer (TNBC) <\/a>lacks estrogen, progesterone, and HER2 receptors, making it more aggressive. <a href=\"https:\/\/www.delveinsight.com\/blog\/hr-positive-her2-negative-breast-cancer-market-trends\">HER2-positive breast cancer<\/a> overexpresses the HER2 protein, while hormone receptor-positive breast cancer includes <a href=\"https:\/\/www.delveinsight.com\/blog\/estrogen-receptor-positive-breast-cancer-market-outlook\">estrogen receptor-positive (ER+),<\/a> progesterone receptor-positive (PR+), and combinations like ER+\/HER2+. Other types include Inflammatory Breast Cancer (IBC), Paget\u2019s Disease of the Breast, Phyllodes Tumors, and Angiosarcoma. Understanding these helps in personalizing treatment for better outcomes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-are-the-causes-of-breast-cancer-nbsp\"><span class=\"ez-toc-section\" id=\"What_are_the_Causes_of_Breast_Cancer\"><\/span>What are the Causes of Breast Cancer?&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The exact breast cancer causes are not fully understood, and ongoing research continues to explore the underlying mechanisms of the disease. Current evidence suggests that breast cancer develops due to a complex interaction of genetic, environmental, and lifestyle-related factors rather than a single identifiable cause. When considering how is breast cancer causes, scientists often point to changes or mutations in DNA that disrupt normal cell growth and division, leading to tumor formation.<\/p>\n\n\n\n<p>Several breast cancer causes risk factors have been identified that may increase the likelihood of developing the disease. These include age, hormonal influences, family history, genetic mutations (such as BRCA1 and BRCA2), reproductive history, lifestyle habits, and environmental exposures. While these factors are associated with a higher risk, they are not definitive causes.<\/p>\n\n\n\n<p>It is important to understand that having one or more breast cancer causes risk factors does not guarantee the development of breast cancer. Likewise, the absence of these risk factors does not eliminate the possibility of the disease. In fact, many individuals diagnosed with breast cancer have no obvious risk factors, while others with several risk factors may never develop it. This variability highlights the complexity of how is breast cancer causes and underscores the need for continued research and awareness.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-some-of-the-risk-factors-for-breast-cancer-are-as-follows-nbsp\"><span class=\"ez-toc-section\" id=\"Some_of_the_Risk_Factors_for_Breast_Cancer_are_as_Follows\"><\/span>Some of the Risk Factors for Breast Cancer are as Follows:&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Age:<\/strong> The risk of getting diagnosed with Breast cancer increases with age. Approximately 80% of women diagnosed with Breast cancer are 50 or older.&nbsp;<\/p>\n\n\n\n<p><strong>Family history:<\/strong> Some people are generally more vulnerable to developing a certain disease because of family history. The same is the case with Breast cancer. It has been observed that having a first-degree relative with Breast cancer almost doubles the risk of Breast cancer. However, this does not mean that in every instance, family history is to be blamed if more than one family member is diagnosed with Breast cancer. Breast cancer is the most common form of cancer in women, and it can be purely by chance as well.&nbsp;<\/p>\n\n\n\n<p><strong>Mutations:<\/strong> Talking about family history, if breast cancer runs in the genes of the family, there is a chance that some mutations, i.e., changes in the genomic mapping of the person, will be passed down to the next generations. In the case of Breast cancer, inherited mutations in certain genes such as BRCA1 (BReast CAncer gene one) and BRCA2 (BReast CAncer gene two) render women at higher risk of Breast cancer. Talking about why a mutation in this particular gene might be causing Breast cancer can be attributed to the primary role of the gene, which is to serve the damaged cells and manage the normal cell growth in breasts and ovaries.<\/p>\n\n\n\n<p><strong>Dense breasts:<\/strong> Having a dense pair usually means having more connective and glandular tissue than fatty tissue. Women with dense breasts, which are approximately 10% of the total women population, are put at a higher risk of developing Breast cancer. Further, due to difficulties in distinguishing between dense tissues and tumors, as they both appear white on mammograms. This further delays the diagnosis and increases the severity of Breast cancer.&nbsp;&nbsp;<\/p>\n\n\n\n<p><strong>Reproductive history:<\/strong> It is a well-known fact that reproductive history significantly influences the chances of Breast cancer. Several studies have noted that women who have abnormalities in the number or timing of pregnancies, age of menarche, and menopause often increase the risk of developing Breast cancer.&nbsp;<\/p>\n\n\n\n<p><strong>Hormonal levels:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/blog\/how-her2-breast-cancer-emerging-drugs-will-transform-market\/\">Elevated levels of hormones<\/a>, namely estrogen and progesterone, are also associated with uncontrolled cell growth.&nbsp;<\/p>\n\n\n\n<p><strong>History of Breast cancer lump:<\/strong> A history of certain previous types of breast lumps or early non-invasive breast cancer also renders women susceptible to cancer.&nbsp;<\/p>\n\n\n\n<p><strong>Radiation therapy:<\/strong> Medical procedures such as CT scans or X-rays of the chest increase the risk of developing Breast cancer. Radiation therapy to breast to treat Hodgkin lymphoma, for instance, also increases the risk of developing Breast cancer.&nbsp;<\/p>\n\n\n\n<p>Besides obesity, alcohol consumption and a sedentary lifestyle also increase the risk of developing Breast cancer.&nbsp;<\/p>\n\n\n\n<p>While there are <a href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-myths\">many myths about breast cancer<\/a>, it&#8217;s essential to recognize the symptoms to watch for when detecting breast cancer.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"750\" height=\"420\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16133152\/Beast-cancer-risk-factors.jpg\" alt=\"Breast Cancer Risk Factors | Breast Cancer Symptoms\" class=\"wp-image-11040\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16133152\/Beast-cancer-risk-factors.jpg 750w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16133152\/Beast-cancer-risk-factors-300x168.jpg 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16133152\/Beast-cancer-risk-factors-20x11.jpg 20w\" sizes=\"(max-width: 750px) 100vw, 750px\" \/><figcaption class=\"wp-element-caption\"><strong>Breast Cancer Risk Factors<\/strong><\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-can-you-reduce-the-chances-of-breast-cancer-nbsp\"><span class=\"ez-toc-section\" id=\"How_can_you_Reduce_the_Chances_of_Breast_Cancer\"><\/span>How can you Reduce the Chances of Breast Cancer?&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>While it is necessary to keep track of the body, understand the symptoms of breast cancer, and get regular check-ups done in order to detect any form of abnormality, it is also important to refrain from adopting habits that somehow contribute to the chances of developing breast cancer. To effectively manage and reduce the risk of breast cancer, adhering to <strong>key precautions for breast cancer<\/strong> is crucial. Regular breast exams, including both self-exams and clinical evaluations, play a vital role in early detection. Women should perform self-exams monthly and schedule clinical exams annually with a healthcare professional. Additionally, regular mammograms are essential, as they can identify tumors or abnormalities before they are palpable. The American Cancer Society advises starting annual mammograms at age 40 or earlier for those with a family history or other risk factors. Incorporating these precautions into routine health practices can significantly enhance early detection and prevention efforts. There are certain things that lie in the hands of the individual that can lower the risks of breast cancer.&nbsp;<\/p>\n\n\n\n<p>Limit alcohol intake as the alcohol increases the level of estrogen in the body hence the chances of breast cancer.&nbsp;<\/p>\n\n\n\n<p>Cease smoking because it is linked with changes in the morphology of normal breast cells leading to an increase in mobility and turning them into fibroblasts, which are the major cellular components of tumors.&nbsp;<\/p>\n\n\n\n<p>Regulate weight because obesity comes from several other health implications, and it also increases the risk of Breast cancer.&nbsp;<\/p>\n\n\n\n<p>As a sedentary lifestyle, regular exercise results in being overweight, bad posture, and other health conditions. Studies have revealed that women who exercise regularly are at lower risk of developing Breast cancer than women who lead a physically inactive life.&nbsp;<\/p>\n\n\n\n<p>A healthy diet is key to leading a qualitative life and plays a crucial role in preventing Breast cancer.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-what-are-the-early-signs-of-breast-cancer\"><span class=\"ez-toc-section\" id=\"What_are_the_Early_Signs_of_Breast_Cancer\"><\/span>What are the Early Signs of Breast Cancer?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>First and foremost, it is necessary for women to be vigilant and understand their breasts. By noticing, feeling, and checking their breasts regularly, women can notice subtle signs of Breast cancer.&nbsp;<\/p>\n\n\n\n<p>The signs and symptoms of Breast cancer vary with individuals. Some of the early signs of Breast cancer in the body are:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>A lump or swelling that might not be visible to the eye but can be felt in the breast, armpits, or chest<\/li>\n\n\n\n<li>A change in the color of the skin of the breast<\/li>\n\n\n\n<li>Nipple inversion or rashes around the nipple&nbsp;<\/li>\n\n\n\n<li>Any unusual discharge from either of the nipples&nbsp;<\/li>\n\n\n\n<li>Sudden changes in the size or shape of the breasts&nbsp;<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-how-do-these-signs-differ-in-case-breast-cancer-has-spread-to-other-parts-nbsp\"><span class=\"ez-toc-section\" id=\"How_do_These_Signs_Differ_in_Case_Breast_Cancer_has_Spread_to_Other_Parts\"><\/span>How do These Signs Differ in Case, Breast Cancer has Spread to Other Parts?&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>However, if, due to negligence or some other reason, there is a delay in the treatment of Breast cancer, it can spread to other organs or parts of the body. Symptoms or signs that signify that Breast cancer has spread to other parts of the body are:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sudden bone pain. Bone fractures due to minimal injuries. Increased levels of calcium in the blood.&nbsp;<\/li>\n\n\n\n<li>Pain in ribs. Loss of appetite. Jaundice. Anemia. Sudden weight loss. Vomiting.<\/li>\n\n\n\n<li>Affected lungs. Breathing shortage. Persistent coughing.&nbsp;<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-when-and-how-is-breast-cancer-diagnosed-nbsp\"><span class=\"ez-toc-section\" id=\"When_and_How_is_Breast_Cancer_Diagnosed\"><\/span>When and How is Breast Cancer Diagnosed?&nbsp;<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>There is no hard and fast rule that after noticing the symptoms, only a person should get checked for <a href=\"https:\/\/www.delveinsight.com\/report-store\/hr-positive-her2-negative-breast-cancer-market-insights\">Breast cancer.<\/a> Whether there are symptoms or not, whether the woman has a family history or not, it is necessary to get routine check-ups for Breast cancer. Physicians use different diagnostics methods to detect Breast cancer. Some of the diagnosis methodologies are:&nbsp;<\/p>\n\n\n\n<p>Screening tests are routine tests performed on women who have no symptoms of breast cancer and appear healthy. These tests, however, are very helpful in detecting cancers at the earliest possible stages. Screening includes laboratory tests to check blood for the presence of biomarkers and other fluids, genetic tests in case there is a suspicion of family history, and Imaging Tests such as Ultrasound, Mammography, and MRI.&nbsp;<\/p>\n\n\n\n<p>If something is detected during the Screening, then a Biopsy is performed. In this process, with the help of a needle, a small amount of breast tissue is removed for examination and confirms the diagnosis of Breast cancer.&nbsp;&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-are-the-treatment-options-available-for-breast-cancer\"><span class=\"ez-toc-section\" id=\"What_are_the_Treatment_Options_Available_for_Breast_Cancer\"><\/span>What are the Treatment Options Available for Breast Cancer?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>With advancements in technology, there is an improvement in the treatment of Breast cancer. Physicians opt for a multidisciplinary approach comprising a combination of treatment options depending on the type, severity, and stage of Breast cancer.&nbsp;<\/p>\n\n\n\n<p>Surgery is the first treatment option to remove the tumor safely. Safe resection to remove either a part of the breast (lumpectomy) or the whole of the breast (mastectomy) is often considered; however, it is based on the location and size of the tumor. Further, there are other newer surgical options as well that improve the appearance of the breast, such as Skin-sparing mastectomy and nipple-sparing mastectomy.&nbsp;<\/p>\n\n\n\n<p>Radiation therapy is used after surgery to kill the remaining cancerous cells. A proper angle, a correct dose, and an accurate location are decided first, and then the patient is subjected to radiation therapy. External beam radiation on the whole of the breast is also used several times. However, the areas where radiation therapy is given depend on where the tumor has spread.&nbsp;<\/p>\n\n\n\n<p>Chemotherapy is another standard and viable treatment option for breast cancer patients. Chemotherapy uses a combination of drugs and is given either before or after the surgery to kill or shrink the size of the cancerous cells, which would otherwise be hard to remove with the help of surgery.&nbsp;<\/p>\n\n\n\n<p>Hormone therapy, also known as hormone-blocking therapy, is used to prevent the recurrence of breast cancers by preventing hormones, especially estrogen, from accelerating the growth of the tumor.&nbsp;<\/p>\n\n\n\n<p>Targeted therapy, which uses targeted drug treatments, targets abnormalities within the cells to simmer down the overproduction of cancerous cells. These therapies target cells that overproduce proteins, such as human epidermal growth factor receptor 2 (HER2), which helps breast cancer cells grow and provides nourishment. Immunotherapy is a type of biological therapy that uses the body\u2019s immune cells to tackle cancer.&nbsp;<\/p>\n\n\n\n<p>Besides available treatment options, several clinical trials are ongoing to bring novel and more efficient treatment options as well as diagnosis methods for patients living with breast cancer. As one of the pioneers in breast cancer treatment, <a href=\"https:\/\/www.delveinsight.com\/blog\/roches-her2-positive-breast-cancer-therapies\">Roche\u2019s dedication began<\/a> with the FDA approval of its first drug, HERCEPTIN (trastuzumab), on September 25, 1998. Since then, HERCEPTIN has played a pivotal role in transforming HER2+ breast cancer therapy. Subsequent approvals, such as the FDA&#8217;s approval of PERJETA (pertuzumab) in June 2012, KADCYLA (ado-trastuzumab emtansine) in February 2013, and PHESGO (fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase\u2013zzx) in June 2020, have further expanded Roche&#8217;s <a href=\"https:\/\/www.delveinsight.com\/blog\/metastatic-her2-positive-breast-cancer\">HER2-targeted treatment options<\/a>. These therapies have been instrumental in improving survival rates and quality of life for breast cancer patients globally.<\/p>\n\n\n\n<p>There is also a heightened awareness in the population to understand and recognize early symptoms of breast cancer. Increased awareness and the expanding use of approved breast cancer drugs are driving this shift. Leading players in this space include <strong>Olema Pharmaceuticals, Arvinas, Immutep, AstraZeneca, Roche\/Genentech, Evexta Bio, EQRx, Sermonix Pharmaceuticals, Veru Pharma, Evgen Pharma, Eli Lilly,<\/strong> and others. <a href=\"https:\/\/www.delveinsight.com\/blog\/hr-positive-her2-negative-breast-cancer-market-trends\">Several approved therapies<\/a> in the market are efficient in improving patient outcomes. Today, the main focus of therapy remains to improve the overall survival rate, increase the quality of life, and prevent the recurrence of cancer. However, with the expansion of medical science, sooner, there will be feasible personalized treatment approaches to treat breast cancer patients.<\/p>\n\n\n\n<p>Emerging drugs have the potential to <a href=\"https:\/\/www.delveinsight.com\/blog\/how-her2-breast-cancer-emerging-drugs-will-transform-market\">transform the breast cancer market<\/a> significantly. Novel treatments targeting specific genetic markers and pathways are being developed, promising more precise and effective therapies. These advancements include targeted therapies, immunotherapies, and combination treatments that offer hope for better outcomes and fewer side effects. As these emerging drugs progress through clinical trials and gain approval, they will likely become integral components of breast cancer treatment regimens. This transformation will improve survival rates and enhance patients&#8217; quality of life, offering more personalized and tailored treatment options that address the unique characteristics of each individual&#8217;s cancer.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-conclusion\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The landscape of breast cancer treatment is undergoing a remarkable transformation, fueled by innovative therapies and a deeper understanding of the disease. The advancements in the treatment and management of <a href=\"https:\/\/www.delveinsight.com\/blog\/hr-positive-her2-negative-breast-cancer\">HR+\/HER2\u2212 breast cancer<\/a>, alongside the development of new approved drugs and targeted therapies, are reshaping patient care. This progress is not only improving survival rates but also enhancing the quality of life for patients worldwide.<\/p>\n\n\n\n<p>The continued evolution in breast cancer treatment includes significant strides in therapies for various types of breast cancer, such as Triple-Negative Breast Cancer (TNBC), HER2-positive breast cancer, and hormone receptor-positive subtypes. Emerging therapies and novel treatments targeting specific genetic markers and pathways are promising more precise and effective options. As these drugs advance through clinical trials and gain approval, they will become integral to treatment regimens, offering hope for better outcomes and fewer side effects.<\/p>\n\n\n\n<p>As we look to the future, the integration of these cutting-edge treatments will continue to transform the standards of care, ensuring that breast cancer patients receive the most effective and personalized treatment options available. This ongoing innovation and dedication to improving patient outcomes mark a new era in breast cancer management, offering renewed hope for those affected by this challenging disease.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/breast-cancer-market\"><img decoding=\"async\" width=\"1024\" height=\"194\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/08\/16104436\/Breast-Cancer-Banner-1024x194.png\" alt=\"Breast-Cancer-Banner\" class=\"wp-image-29183\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/08\/16104436\/Breast-Cancer-Banner-1024x194.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/08\/16104436\/Breast-Cancer-Banner-300x57.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/08\/16104436\/Breast-Cancer-Banner-150x28.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/08\/16104436\/Breast-Cancer-Banner-768x145.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/08\/16104436\/Breast-Cancer-Banner-1536x291.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/08\/16104436\/Breast-Cancer-Banner.png 1584w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<p><strong>FAQs<\/strong><\/p>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1757508334627\"><strong class=\"schema-faq-question\"><strong>How common is Triple-Negative Breast Cancer (TNBC) compared to other subtypes?<\/strong><\/strong> <p class=\"schema-faq-answer\">TNBC accounts for about 10\u201320% of all breast cancer cases, making it less common than HR+\/HER2\u2212 breast cancer, which dominates with incidence rates as high as 87.2% per 100,000 women in the U.S. TNBC is considered more aggressive because it lacks hormone receptors and HER2 amplification, limiting treatment options.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1757508335875\"><strong class=\"schema-faq-question\"><strong>What proportion of TNBC cases are linked to BRCA1 mutations?<\/strong><\/strong> <p class=\"schema-faq-answer\">Around 3.8K TNBC cases in 2023 across the EU4 &amp; UK were found to be BRCA1-mutated. Since BRCA1 mutations impair the cell\u2019s ability to repair DNA, women carrying these mutations face a significantly higher lifetime risk of developing TNBC.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1757508336436\"><strong class=\"schema-faq-question\"><strong>Which therapies dominate the TNBC treatment space today?<\/strong><\/strong> <p class=\"schema-faq-answer\"><strong>KEYTRUDA <\/strong>(pembrolizumab), combined with chemotherapy, currently holds the largest market share, generating approximately <strong>$1.8 billion in revenue across the 7MM in 2023<\/strong>. Its role as an immune checkpoint inhibitor has made it a game-changer for advanced TNBC cases.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1757508337660\"><strong class=\"schema-faq-question\"><strong>Why does HR+\/HER2\u2212 breast cancer dominate the breast cancer landscape?<\/strong><\/strong> <p class=\"schema-faq-answer\">This subtype accounts for the majority of cases due to its strong association with hormonal risk factors and postmenopausal status. In 2023, the U.S. reported about <strong>208,000 HR+\/HER2\u2212 cases<\/strong>, most in women aged 60\u201379 years. Germany led the EU4 &amp; UK with 50K cases, while Japan reported 43K.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1757508338356\"><strong class=\"schema-faq-question\"><strong>At what stage is TNBC most commonly diagnosed in the U.S.?<\/strong><\/strong> <p class=\"schema-faq-answer\">Nearly half (47%) of TNBC cases in the U.S. were diagnosed at Stage II in 2023. Stage III accounted for 28%, Stage I for 19%, and Stage IV for 5%. This distribution underscores the importance of early detection, as a substantial proportion is still being diagnosed at locally advanced stages.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1757508418622\"><strong class=\"schema-faq-question\"><strong>What is the economic burden of breast cancer, particularly TNBC, in the 7MM?<\/strong><\/strong> <p class=\"schema-faq-answer\">The breast cancer market size across the 7MM reached USD 4.2 billion in 2023, with TNBC contributing significantly due to its aggressive nature and reliance on chemotherapy plus immunotherapy. The U.S. alone represented 69% of this market.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1757508419809\"><strong class=\"schema-faq-question\"><strong>How has Roche shaped the treatment landscape of HER2+ breast cancer?<\/strong><\/strong> <p class=\"schema-faq-answer\">Roche pioneered HER2-targeted therapy with HERCEPTIN (trastuzumab), approved by the FDA in 1998. Since then, it has expanded options with PERJETA (2012), KADCYLA (2013), and PHESGO (2020). These treatments have dramatically improved survival and quality of life for HER2+ patients worldwide.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1757508453841\"><strong class=\"schema-faq-question\"><strong>What emerging trends will define the future of breast cancer treatment?<\/strong><\/strong> <p class=\"schema-faq-answer\">The future lies in <strong>personalized medicine<\/strong>, with therapies targeting genetic mutations (e.g., BRCA), novel immunotherapies, and precision-guided drug combinations. Clinical trials are rapidly advancing, offering hope for more tailored treatments with fewer side effects.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Breast cancer is the most common form of cancer in women. Each year, it affects over 2 million women globally and is the most significant cause of death among women. Among the many types of breast cancer, a particularly formidable foe is Triple-negative breast cancer (TNBC), which accounts for 10-20% of all cases. Other than [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":29188,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[127,1911,644,3878],"industry":[17225],"therapeutic_areas":[17228],"class_list":["post-11032","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-breast-cancer","tag-breast-cancer-awareness-month","tag-breast-cancer-report","tag-breast-cancer-treatment","industry-pharmaceutical","therapeutic_areas-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Breast Cancer Symptoms, Risk Factors, and Treatment<\/title>\n<meta name=\"description\" content=\"What are the causes, risk factors, symptoms, and treatments available for Breast cancer? Breast cancer affects over 2 M women globally...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breast Cancer Symptoms, Risk Factors, and Treatment\" \/>\n<meta property=\"og:description\" content=\"What are the causes, risk factors, symptoms, and treatments available for Breast cancer? Breast cancer affects over 2 M women globally...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-14T08:07:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-20T12:17:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16105803\/Breast-Cancer-Insights.png\" \/>\n\t<meta property=\"og:image:width\" content=\"466\" \/>\n\t<meta property=\"og:image:height\" content=\"284\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Sandeep Joshi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandeep Joshi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"14 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Breast Cancer Symptoms, Risk Factors, and Treatment","description":"What are the causes, risk factors, symptoms, and treatments available for Breast cancer? Breast cancer affects over 2 M women globally...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment","og_locale":"en_US","og_type":"article","og_title":"Breast Cancer Symptoms, Risk Factors, and Treatment","og_description":"What are the causes, risk factors, symptoms, and treatments available for Breast cancer? Breast cancer affects over 2 M women globally...","og_url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2024-08-14T08:07:00+00:00","article_modified_time":"2026-03-20T12:17:38+00:00","og_image":[{"width":466,"height":284,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16105803\/Breast-Cancer-Insights.png","type":"image\/png"}],"author":"Sandeep Joshi","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Sandeep Joshi","Est. reading time":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["WebPage","FAQPage"],"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment","url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment","name":"Breast Cancer Symptoms, Risk Factors, and Treatment","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16105803\/Breast-Cancer-Insights.png","datePublished":"2024-08-14T08:07:00+00:00","dateModified":"2026-03-20T12:17:38+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a"},"description":"What are the causes, risk factors, symptoms, and treatments available for Breast cancer? Breast cancer affects over 2 M women globally...","mainEntity":[{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508334627"},{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508335875"},{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508336436"},{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508337660"},{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508338356"},{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508418622"},{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508419809"},{"@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508453841"}],"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16105803\/Breast-Cancer-Insights.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16105803\/Breast-Cancer-Insights.png","width":466,"height":284,"caption":"Breast Cancer Insights"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/f1eefd8dd4afdb0617d6166f8b301e0a","name":"Sandeep Joshi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7676451175fe155887a18ffb50e674b270d87436a3fc34ca206f86921cddf4cd?s=96&d=mm&r=g","caption":"Sandeep Joshi"},"sameAs":["http:\/\/Delveinsight.com"]},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508334627","position":1,"url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508334627","name":"How common is Triple-Negative Breast Cancer (TNBC) compared to other subtypes?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"TNBC accounts for about 10\u201320% of all breast cancer cases, making it less common than HR+\/HER2\u2212 breast cancer, which dominates with incidence rates as high as 87.2% per 100,000 women in the U.S. TNBC is considered more aggressive because it lacks hormone receptors and HER2 amplification, limiting treatment options.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508335875","position":2,"url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508335875","name":"What proportion of TNBC cases are linked to BRCA1 mutations?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Around 3.8K TNBC cases in 2023 across the EU4 &amp; UK were found to be BRCA1-mutated. Since BRCA1 mutations impair the cell\u2019s ability to repair DNA, women carrying these mutations face a significantly higher lifetime risk of developing TNBC.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508336436","position":3,"url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508336436","name":"Which therapies dominate the TNBC treatment space today?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"<strong>KEYTRUDA <\/strong>(pembrolizumab), combined with chemotherapy, currently holds the largest market share, generating approximately <strong>$1.8 billion in revenue across the 7MM in 2023<\/strong>. Its role as an immune checkpoint inhibitor has made it a game-changer for advanced TNBC cases.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508337660","position":4,"url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508337660","name":"Why does HR+\/HER2\u2212 breast cancer dominate the breast cancer landscape?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"This subtype accounts for the majority of cases due to its strong association with hormonal risk factors and postmenopausal status. In 2023, the U.S. reported about <strong>208,000 HR+\/HER2\u2212 cases<\/strong>, most in women aged 60\u201379 years. Germany led the EU4 &amp; UK with 50K cases, while Japan reported 43K.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508338356","position":5,"url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508338356","name":"At what stage is TNBC most commonly diagnosed in the U.S.?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Nearly half (47%) of TNBC cases in the U.S. were diagnosed at Stage II in 2023. Stage III accounted for 28%, Stage I for 19%, and Stage IV for 5%. This distribution underscores the importance of early detection, as a substantial proportion is still being diagnosed at locally advanced stages.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508418622","position":6,"url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508418622","name":"What is the economic burden of breast cancer, particularly TNBC, in the 7MM?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The breast cancer market size across the 7MM reached USD 4.2 billion in 2023, with TNBC contributing significantly due to its aggressive nature and reliance on chemotherapy plus immunotherapy. The U.S. alone represented 69% of this market.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508419809","position":7,"url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508419809","name":"How has Roche shaped the treatment landscape of HER2+ breast cancer?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Roche pioneered HER2-targeted therapy with HERCEPTIN (trastuzumab), approved by the FDA in 1998. Since then, it has expanded options with PERJETA (2012), KADCYLA (2013), and PHESGO (2020). These treatments have dramatically improved survival and quality of life for HER2+ patients worldwide.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508453841","position":8,"url":"https:\/\/www.delveinsight.com\/blog\/breast-cancer-symptoms-causes-treatment#faq-question-1757508453841","name":"What emerging trends will define the future of breast cancer treatment?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The future lies in <strong>personalized medicine<\/strong>, with therapies targeting genetic mutations (e.g., BRCA), novel immunotherapies, and precision-guided drug combinations. Clinical trials are rapidly advancing, offering hope for more tailored treatments with fewer side effects.","inLanguage":"en-US"},"inLanguage":"en-US"}]}},"author_meta":{"display_name":"Sandeep Joshi","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/sjoshidelveinsight-com"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/10\/16105803\/Breast-Cancer-Insights-300x183.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Breast Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">BREAST CANCER AWARENESS MONTH<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Breast Cancer Report<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">breast cancer treatment<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Breast Cancer<\/span>","<span class=\"advgb-post-tax-term\">BREAST CANCER AWARENESS MONTH<\/span>","<span class=\"advgb-post-tax-term\">Breast Cancer Report<\/span>","<span class=\"advgb-post-tax-term\">breast cancer treatment<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 2 years ago","modified":"Updated 2 months ago"},"absolute_dates":{"created":"Posted on Aug 14, 2024","modified":"Updated on Mar 20, 2026"},"absolute_dates_time":{"created":"Posted on Aug 14, 2024 1:37 pm","modified":"Updated on Mar 20, 2026 5:47 pm"},"featured_img_caption":"Breast Cancer Insights","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/11032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=11032"}],"version-history":[{"count":9,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/11032\/revisions"}],"predecessor-version":[{"id":34792,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/11032\/revisions\/34792"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/29188"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=11032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=11032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=11032"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=11032"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=11032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}